Brand (Generic) Name |
Sections Modified
|
Summary of Changes to Contraindications and Warnings |
Epzicom (abacavir sulfate and lamivudine)
Tablets
Prescribing Information and Medication Guide
|
BOXED WARNING
CONTRAINDICATIONS
WARNINGS
PRECAUTIONS
- Myocardial Infarction
- In a published...the use of abacavir within the previous 6 months was correlated with an increased risk of myocardial infarction (MI)...
MEDICATION GUIDE
- revised to include information related to myocardial infarction
|
BOXED WARNING
- Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitvity reaction to abacavir. Prior to initiating therapy .....
- Regardless of HLA-B*5701 status permanently discontinue Epzicom if hypersensitivity cannot be ruled out...
- Following a hypersensitivity reaction to abacavir, NEVER restart Epzicom... severe symptoms can occur within hours .....
- Reintroduction of Epzicom or any other abacavir-containing product...can result in serious or fatal .....
CONTRAINDICATIONS
- Never restart Epzicom or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B*5701 status....
WARNINGS
- ...Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitivity reaction to abacavir...
|
|
|
|
OsmoPrep (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets
Prescribing Information and Medication Guide
See MedWatch Safety Alert posted 12/11/2008 for additional information on OsmoPrep labeling revisions. |
BOXED WARNING
ADVERSE REACTIONS
- Postmarketing Experience
- General
- Added (tongue) ..swelling of the lips and tongue..
- Cardiovascular: Arrhythmias
- Nervous system: Seizures
- Renal
- acute phosphate nephropathy added
MEDICATION GUIDE
|
BOXED WARNING
- There have been rare, but serious reports of acute phosphate nephropathy in patients who received oral sodium phosphate products for colon cleansing prior to colonoscopy. Some cases have resulted in permanent impairment of renal function and some patients required long-term dialysis. While some cases have occurred in patients without identifiable risk factors, patients at increased risk of acute phosphate nephropathy may include ....
|
|
|
|
Raptiva (efalizumab)
Prescribing Information and Medication Guide
See MedWatch Safety Alert posted 01/19/2009 for additional information on Raptiva labeling revisions. |
BOXED WARNING
CONTRAINDICATIONS
WARNINGS
- Progressive Multifocal Leukoencephalopathy (PML)
PRECAUTIONS
- Information for Patients
- Healthcare providers should counsel patients about the risks and benefits of Raptiva...
ADVERSE REACTIONS
- The most serious adverse reactions observed during treatment with Raptiva are serious infections, including PML...
- In postmarketing experience, serious bacterial, viral, fungal, and opportunistic infections
have occurred, including JC virus infection resulting in PML...
MEDICATION GUIDE
- Conversion of the Patient Package Insert to a Medication Guide
|
BOXED WARNING
- Warning: Risk of Progressive Mutifocal Leukoencephalopathy (PML)
- Raptiva increases the risk for PML, a rapidly progressive viral infection of the central nervous system that...
- Patients on Raptiva should be monitored frequently...
- Raptiva dosing should be withheld immediately at the first sign or symptom suggestive of PML...
CONTRAINDICATIONS
- should not be administered to patients who have been diagnosed with PML
WARNINGS
- Progressive Multifocal Leukoencephalopathy (PML)
- PML is a rapidly progressive infection of the central nervous system caused by the JC virus that leads to death or severe disability.
- Raptiva increases the risk for PML and this risk may markedly increase with longer duration ..... Post-marketing cases...
- The effect of intermittent use of Raptiva...
- Healthcare providers treating patients with Raptiva should consider...
|
|
|
|
Sporanox (itraconazole) Oral Solution, 10 mg/mL
Prescribing Information
|
BOXED WARNING
CONTRAINDICATIONS
- Congestive Heart Failure
- Drug Interactions
WARNINGS
- Cardiac Dysrhythmias
- Cardiac Disease
- Treatment of Severely Neutropenic Patients
PRECAUTIONS
- Hearing Loss
- Transient or permanent hearing loss has been reported .....
- Information for Patients
- Instruct patients that hearing loss can occur...
- Drug Interactions Table additions
- ...disopyramide..(including nisoldipine)..levacetylmethadol (levomethadyl), ergot alkaloids, halofantrine..budesonide,
dexamethasone, fluticasone..warfarin, cilostazol, eletriptan, fentanyl...
- Antiarrhythmics
- The class IA antiarrhythmic disopyramide has the potential to increase the QT interval...
- ...via inhibition of P glycoprotein.
- Calcium Channel Blockers
- ...due to an increased risk of CHF. Concomitant administration of Sporanox and nisoldipine results in...
- Other
- Levacetylmethadol (levomethadyl) is known to prolong the QT...
- Elevated concentrations of ergot alkaloids can cause ergotism...
- Halofantrine has the potential to prolong the QT interval...
- Sporanox may..."glucocorticosteroids such as budesonide, dexamethasone, fluticasone and"...
- Cilostazol and eletriptan are CYP3A4 metabolized...
- Fentanyl plasma concentrations could...
- Pregnancy:Teratogenic Effects, Pregnancy Category C
- During post-marketing experience, cases of congenital abnormalities have been reported.
- Geriatric Use (new section)
- Renal Impairment (new section)
- Hepatic Impairment (new section)
ADVERSE REACTIONS
- Postmarketing Experience
- Revised and table updated
- Transient or permanent hearing loss
|
BOXED WARNING
- Drug Interactions
- Coadministration of "levacetylmethadol (levomethadyl)" addition
- ..sudden death have occurred in patients using "levacetylmethadol (levomethadyl)"...
CONTRAINDICATIONS
- Congestive Heart Failure (new section)
- Drug Interactions
- nisoldipine
- levacetylmethadol
(levomethadyl)
- Ergot alkaloids metabolized...
WARNINGS
- Cardiac Dysrhythmias
- levacetylmethadol (levomethadyl)
- Cardiac Disease
- Itraconazole has been shown to have a negative inotropic effect.
- Sporanox has been associated with reports of congestive heart failure. In post-marketing...
- Calcium channel blockers can have negative inotropic effects
- Treatment of Severely Neutropenic Patients (new section)
|
|
|
|
Trizivir (abacavir sulfate, lamivudine, and
zidovudine) Tablets
Prescribing Information
|
BOXED WARNING
CONTRAINDICATIONS
WARNINGS
- Hypersensitivity Reaction
PRECAUTIONS
MEDICATION GUIDE
- Observed During Clinical Practice
- Cardiovascular: Myocardial infarction.
|
BOXED WARNING
- Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitvity reaction to abacavir...
CONTRAINDICATIONS
- Trizivir tablets are contraindicated in patients with previously demonstrated hypersensitivity to abacavir or to any other component of the product...
- Never restart Trizivir or any other abacavir-containing product...
WARNINGS
- Hypersensitivity Reaction
- Serious and sometimes fatal hypersensitivity reactions have
been associated with Trizivir...
- HLA-B*5701-negative patients may develop a hypersensitivity reaction to abacavir...
|
|
|
|
Visicol Tablets
(sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP)
Prescribing Information and Medication Guide
See MedWatch Safety Alert posted 12/11/2008 for additional information on Visicol labeling revisions. |
BOXED WARNING
ADVERSE REACTIONS
- Postmarketing Experience
- Rewritten to match OsmoPrep format
MEDICATION GUIDE
|
BOXED WARNING
There have been rare, but serious reports of acute phosphate nephropathy in patients who received oral sodium phosphate products for colon cleansing prior to colonoscopy. Some cases have resulted in permanent impairment of renal function and some patients required long-term dialysis. While some cases have occurred in patients without identifiable risk factors, patients at increased risk of acute phosphate nephropathy may include ...
|
Back to Summary Page | Back to Top
Brand (Generic) Name |
Sections Modified
|
Summary of Changes to Contraindications
and Warnings |
Diabeta (glyburide) Tablets
Prescribing Information |
CONTRAINDICATIONS
PRECAUTIONS
- Hemolytic anemia
- There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction
- Drug Interactions
- Clarithromycin (hypoglycemic action of sulfonylureas may be potentiated)
- bosentan and cyclosporine
|
CONTRAINDICATIONS
- hypersensitivity to any of the drug’s excipients and patients treated with bosentan
|
|
|
|
Macrobid (nitrofurantoin monohydrate/macrocrystals) Capsules, 100 mg
Prescribing Information
|
CONTRAINDICATIONS
WARNINGS |
CONTRAINDICATIONS
- Macrodantin is contraindicated in patients with a previous history of cholestatic jaundice/hepatic dysfunction associated with nitrofurantoin.
WARNINGS
- Added subheadings for readability of the following reactions:
- Pulmonary reactions
- Hepatoxicity
- Neuropathy
- Hemolytic anemia
- Clostridium difficile-associated diarrhea
|
|
|
|
Macrodantin (nitrofurantoin monohydrate/macrocrystals) Capsules, 25, 50 and 100 mg
Prescribing Information |
CONTRAINDICATIONS
WARNINGS |
CONTRAINDICATIONS
- Macrodantin is contraindicated in patients with a previous history of cholestatic jaundice/hepatic dysfunction associated with nitrofurantoin.
WARNINGS
- Added subheadings for readability of the following reactions:
- Pulmonary reactions
- Hepatoxicity
- Neuropathy
- Hemolytic anemia
- Clostridium difficile-associated diarrhea
|
|
|
|
Rocephin (ceftriaxone sodium) for injection, 250 mg, 500 mg, 1 g and 2 g
Prescribing Information
|
CONTRAINDICATIONS
WARNINGS
- Interaction with Calcium-Containing Products
ADVERSE REACTIONS
- Postmarketing Experience
- A small number of cases of fatal outcomes in which a crystalline material was observed in the lungs and kidneys at autopsy have been reported...
|
CONTRAINDICATIONS
- Neonates (section edited)
- Rocephin is contraindicated in neonates if they require...
- A small number of cases of fatal outcomes in which a crystalline material was observed in the lungs and kidneys at autopsy...
WARNINGS
- Interaction with Calcium-Containing Products
- Do not use diluents containing calcium, such as Ringer’s solution or Hartmann’s solution, to reconstitute Rocephin vials...
|
|
|
|
Sporanox (itraconazole) Capsules, 100 mg
Prescribing Information and Patient Package Insert
|
CONTRAINDICATIONS
WARNINGS
PRECAUTIONS
- Hearing Loss
- Transient or permanent hearing loss has been reported .....
- Information for Patients
- Instruct patients that hearing loss can occur...
- Antiarrhythmics
- Concomitant administration of digoxin...added "via inhibition of P-glycoprotein"
- Drug Interactions/Calcium Channel Blockers
- added...due to an increased risk of CHF. Concomitant administration of Sporanox and nisoldipine results in...
- Drug Interactions/Other
- fluticasone
- Fentanyl plasma concentrations could be increased or prolonged by concomitant use of Sporanox and may cause potentially fatal respiratory depression
- Geriatric Use
- Transient or permanent hearing loss has been reported...
- Renal Impairment (new)
- Hepatic Impairment (new)
ADVERSE REACTIONS
- Post-marketing Experience
(replaced with table)
- Adverse drug reactions that have been identified during post-approval use of Sporanox (all formulations) are listed ...
PATIENT PACKAGE INSERT
- Who Should Not Take Sporanox and What Are The Possible Side Effects Of Sporanox section
|
CONTRAINDICATIONS
WARNINGS
- Cardiac Disease
- Sporanox has been associated with reports of congestive heart failure. In post-marketing...
- Calcium channel blockers can have negative inotropic effects
|
|
|
|
Sporanox (itraconazole) Injection, 10 mg/mL
Prescribing Information
|
CONTRAINDICATIONS
WARNINGS
PRECAUTIONS
- Hearing Loss
- Transient or permanent hearing loss has been reported ...
- Information for Patients
- Instruct patients that hearing loss can occur...
- Antiarrhythmics
- Concomitant administration of digoxin...added "via inhibition of P-glycoprotein"
- Drug Interactions/Calcium Channel Blockers
- added...due to an increased risk of CHF. Concomitant administration of Sporanox and nisoldipine results in...
- Drug Interactions/Other
- fluticasone
- Fentanyl plasma concentrations could be increased or prolonged by concomitant use of Sporanox and may cause potentially fatal respiratory depression
- Geriatric Use
- Transient or permanent hearing loss has been reported...
- Renal Impairment (new)
- Hepatic Impairment (new)
ADVERSE REACTIONS
- Post-marketing Experience
(replaced with table)
- Adverse drug reactions that have been identified during post-approval use of Sporanox (all formulations) are listed...
PATIENT PACKAGE INSERT
- Who Should Not Take Sporanox and What Are The Possible Side Effects Of Sporanox section
|
CONTRAINDICATIONS
- Drug Interactions
- nisoldipine
- Sporanox IV cannot be used when administration of Sodium Chloride Injection is
contraindicated.
WARNINGS
- Cardiac Disease
- Itraconazole has been shown to have a negative inotropic effect.
- Sporanox has been associated with reports of congestive heart failure. In post-marketing...
- Calcium channel blockers can have negative inotropic effects
|
|
|
|
Theophylline in 5% Dextrose injection, USP, Flexible Plastic Container
Prescribing Information |
CONTRAINDICATIONS
WARNINGS
- When Signs and Symptoms of Theophylline Toxicity are Present
PRECAUTIONS
- Monitoring Serum Theophylline Concentrations
- "Saliva concentrations of theophylline cannot be used reliably to adjust dosage without special techniques...
- Clinical evaluation and periodic laboratory determinations are necessary to monitor changes...
- ..Do not use plastic container in series connection...
- ..These solutions are intended for intravenous administration...
- ..Use only if solution is clear and container and seals are intact.
ADVERSE REACTIONS
- Hypercalcemia has been reported in a patient with hyperthyroid disease at therapeutic theophylline concentrations.
- “Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.
|
CONTRAINDICATIONS
- Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products
WARNINGS
- When Signs and Symptoms of Theophylline Toxicity are Present
- “Solutions containing dextrose without electrolytes should not be administered simultaneously with blood through the same infusion set... ...Because dosages of these drugs are titrated to response, no additives should be made to Theophylline in 5% Dextrose Injection USP."
|
|
|
|
Tracleer (bosentan) 62.5 and 125 mg Tablets
Prescribing Information and Medication Guide
|
CONTRAINDICATIONS
- Lopinavir/ritonavir or other ritonavir-containing HIV regimens
PRECAUTIONS
- Drug Interactions
(section reworded)
- Bosentan is metabolized by CYP2C9 and CYP3A4. Inhibition of these enzymes may increase the plasma concentration of bosentan...
- Lopinavir/ritonavir or other ritonavir-containing HIV regimens
- Co-administration of Tracleer in healthy subjects resulted in initial and steady...
MEDICATION GUIDE
- Do not take Tracleer if...
- lopinavir/ritonavir or other ritonavir-containing HIV regimens
- Tell your doctor about all the medicines you use..
- lopinavir/ritonavir or other ritonavir-containing HIV regimens
- What should I avoid..
- Do not take cyclosporine-A...increase your chance of side effects
- Do not take lopinavir/ritonavir or other ritonavir-containing HIV regimens
|
CONTRAINDICATIONS
- Lopinavir/ritonavir or other ritonavir-containing HIV regimens
- Co-administration of lopinavir/ritonavir and bosentan resulted in markedly increased plasma concentrations of bosentan.Therefore, concomitant use of Tracleer and lopinavir/ritonavir or other ritonavir-containing HIV regimens is contraindicated...
|
Back to Summary Page | Back to Top
Brand (Generic) Name |
Sections Modified
|
Summary of Changes to Contraindications
and Warnings |
Advair Diskus (fluticasone propionate and salmeterol xinafoate inhalation powder)
The latest label (3/31/2009) is not available on this site |
WARNINGS AND PRECAUTIONS
- Reduction in Bone Mineral Density
|
WARNINGS and PRECAUTIONS
- Reduction in Bone Mineral Density
- 2-Year Fluticasone Propionate Study
- 3-Year Bone Mineral Density Study
- 3-Year Survival Study
|
|
|
|
Altace (ramipril) 1.25, 2.5, 5, and 10 Capsules
Altace (ramipril) 1.25, 2.5, 5 and 10 mg Tablets
The latest label (approved 03/04/2009) is not available on this site |
WARNINGS
- Fetal/Neonatal Morbidity and Mortality
PRECAUTIONS
- Information for Patients/Pregnancy
- Female patients of childbearing age should be told about the consequences of exposure to ACE inhibitors during pregnancy. These patients should be asked to report pregnancies to their physicians as soon as possible.
|
WARNINGS
- Fetal/Neonatal Morbidity and Mortality
- In a published retrospective epidemiological study, infants whose mothers had taken an ACE inhibitor during their first trimester of pregnancy appeared to have an increased risk of major congenital malformations...findings of this study have not yet been confirmed.
|
|
|
|
Axert (almotriptan malate) Tablets 6.25 and 12.5 mg
Prescribing Information
|
WARNINGS
PRECAUTIONS
- Drug Interactions
- Selective Serotonin Reuptake Inhibitors/Serotonin Norephinephrine Reuptake Inhibitors and Serotonin Syndrome
- Information for Patients
- separate leaflet provided for patients
- Patients should be cautioned about the risk of serotonin syndrome...
ADVERSE REACTIONS
- Postmarketing Experience
- Includes reports of seizure in close temporal association with triptan use
PATIENT PACKAGE INSERT
- Includes information concerning serotonin syndrome with concomitant use of triptans and SSRIs/SNRIs
|
WARNINGS
|
|
|
|
Cymbalta (duloxetine hydrochloride) Delayed-
Release Capsules 20, 30 and 60 mg
Prescribing Information |
WARNINGS AND PRECAUTIONS
- Discontinuation of Treatment with Cymbalta
ADVERSE REACTIONS
- Other Adverse Reactions observed during the premarketing and postmarketing clinical trial evaluation of Duloxetine
- Ear and Labyrinth Disorders
- General Disorders and Administration Site Conditions
- Nervous System Disorders
- ...and poor quality sleep
- Renal and Urinary Disorders
- Reproductive System and Breast Disorders
- ...and sexual dysfunction
- Skin and Subcutaneous Tissue Disorders
- Postmarketing Spontaneous Reports
- aggression and anger (particularly early in treatment or after treatment discontinuation)
- gynecological bleeding
- muscle spasm
- restless legs syndrome, seizures upon treatment
discontinuation
- tinnitus (upon treatment discontinuation)
MEDICATION GUIDE
|
WARNINGS and PRECAUTIONS
- Discontinuation of Treatment with Cymbalta
- words "tapered" and "fatigue" inserted in the section
|
|
|
|
Frova (frovatriptan succinate) Tablets 2.5 mg
Prescribing Information
|
WARNINGS AND PRECAUTIONS
ADVERSE REACTIONS
- Postmarketing Experience
- reports of seizure in close temporal association with triptan use
PATIENT PACKAGE INSERT
- information concerning serotonin syndrome with concomitant use of triptans and SSRIs/SNRIs
|
WARNINGS AND PRECAUTIONS
- Includes information concerning serotonin syndrome with concomitant use of triptans and SSRIs/SNRIs
|
|
|
|
Lexiscan (regadenoson) Injection
Prescribing Information
|
WARNINGS AND PRECAUTIONS
ADVERSE REACTIONS
- (6.1) Clinical Trials Experience
- (6.2) Post Marketing Experience
- Cardiovascular
- Gastrointestinal
- Musculoskeletal
- Respiratory
|
WARNINGS AND PRECAUTIONS
- Sinoatrial and Atrioventricular Nodal Block
- In postmarketing experience, third degree heart block and asystole within minutes of Lexiscan administration have occurred
- Hypotension
- In postmarketing experience, syncope and transient ischemic attacks have been observed
|
|
|
|
Spiriva
HandiHaler inhalation powder
Prescribing Information and New Patient Package Insert
|
WARNINGS
ADVERSE REACTIONS
- added "(new onset or worsening)" to glaucoma
PATIENT PACKAGE INSERT
|
WARNINGS
- section updated symptoms of angioedema: (including swelling of the lips, tongue or throat), itching, and rash
|
Back to Summary Page | Back to Top
Brand
(Generic) Name
|
Sections Modified |
NegGram (nalidixic acid) Caplets
Prescribing Information
|
PRECAUTIONS
- General subsection text modified
- Caution should be used in patients with renal insufficiency (term "severe" & "failure" removed) and subsequent sentence removed
|
|
|
Novothyrox (levothyroxine sodium) Tablets
Prescribing Information
|
PRECAUTIONS
- agents such as iron and calcium supplements and antacids can decrease the absorption of levothyroxine tablets
- instructions for reporting side effects to FDA
- drug-drug interaction between levothyroxine and orlistat
|
|
|
Tarka (trandolopril/verapamil hydrochloride) 2/180, 1/240, 2/240, 4/240 mg ER Tablets
The latest label (approved 3/5/2009) is not available on this site
|
PRECAUTIONS
- Drug Interactions (the following interactions have been added):
- Clarithromycin
- Hypotension, bradyarrhythmias, and lactic acidosis have been observed in patients receiving concurrent clarithromycin.
- Erythromycin
- Hypotension, bradyarrhythmias, and lactic acidosis have been observed in patients
receiving concurrent erythromycin ethylsuccinate.
- Gold
- Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including Tarka.
|
|
|
Zithromax (azithromcyin) for Oral Suspension, 200 mg, 500 mg, Single Dose Packet, 600 mg, IV
Prescribing Information
|
PRECAUTIONS
- General
- Exacerbation of symptoms of myasthenia gravis and new onset of myasthenic syndrome have been reported in patients receiving azithromycin therapy.
- Precautions -Drug Interactions
- Although, in a study of 22 healthy men, a 5-day course of azithromycin did not affect the prothrombin time from a subsequently administered dose of warfarin, spontaneous post-marketing reports suggest that concomitant administration of azithromycin may potentiate the effects of oral anticoagulants. Prothrombin times should be carefully monitored while patients are receiving azithromycin and oral anticoagulants concomitantly.
|
Back to Summary Page | Back to Top
Brand
(Generic) Name
|
Sections Modified |
Clinoril (sulindac) Tablets
Prescribing Information |
ADVERSE REACTIONS
- Hypersensitivity Reactions
|
|
|
Cosmegen (dactinomycin) for Injection
Prescribing Information
|
ADVERSE REACTIONS
- Hematologic
Section
- addition of neutropenia and febrile neutropenia
|
|
|
Crestor (rosuvastatin calcium) Tablets
Prescribing Information
|
ADVERSE REACTIONS
|
|
|
Demerol (meperidine hydrochloride) Tablets and Oral Solution
Prescribing Information
|
ADVERSE REACTIONS
- Hypersensitivity reactions including anaphylaxis
|
|
|
Eloxatin (oxaliplatin) powder for solution for intravenous use
Eloxatin (oxaliplatin) concentrate for solution for intravenous use
Prescribing Information |
ADVERSE REACTIONS
- Postmarketing Experience
- after other interstitial lung diseases added "sometimes fatal"
- transient vision loss (reversible following therapy discontinuation)
Information for Patients
- Updated ... vision abnormalities that may affect patients’ ability to drive and
use machines.
|
|
|
Lipitor (atorvastatin calcium) Tablets
Prescribing Information
|
ADVERSE REACTIONS
|
|
|
Niaspan (niacin extended release) tablet
The latest label (approved 03/26/2009) is not available on this site |
ADVERSE REACTIONS
- Post-marketing adverse event
- blurred vision, hepatitis, myopathy, creatine kinase increase, and skin discoloration
|
|
|
Vancocin Hcl (vancomycin for injection, USP) 500 mg/100mL and 1g/200mL
Prescribing Information
|
ADVERSE REACTIONS
- Post Marketing Reports
- Drug Rash with Eosinophilia and Systemic Symptoms (DRESS)
|
Back to Summary Page | Back to Top
Back to Summary Page | Back to Top
|
|